Long-term efficacy of single-dose oral treatment in schistosomiasis haematobium

Abstract
A two-year follow-up was conducted in children who had been the subjects of a six-month double-blind trial in the single-dose treatment of Schistosoma haematobium infection. The trial had assessed therapeutic efficacy of three oral preparations—praziquantel 40 mg/kg, metrifonate 10 mg/kg, and the “combination” (concurrent niridazole 25 mg/kg and metrifonate 10 mg/kg administration).